Non-traditional treatment of blood pressure in black barbershops. Read what happenedTake a nap to reduce blood pressure. Read about the study
As the call for Late Breaking Trials goes out for Heart Failure 2018, have a look at the video interviews from last year's congress on QUAILIFY, CHARM, TRUE6AHF and others on HFA News page.
The paracrine hypothesis 2018: extracellular (EC) vesicles recapitulate the therapeutic effects of cells, and may protect from heart failure. Find out more
Heart Failure: a precancerous state? This study shows that the presence of heart failure may predispose to tumor growth. Read the study
Gout is a risk factor for HF development. However, whether treatment of gout is beneficial remains unknown. This small scale trial suggest that the drug probenecid may be effective in treating gout and heart disease. Here's the link
Interesting interaction between the (‘arrhythmogenic’) gene SCNA5A and heart failure: genetic variants in the SCN5A gene should prompt evaluation of rhythm disturbances but also heart failure! Read the article
New HFpEF drug at the horizon: Researchers from the University of Colorado demonstrated that the drug ITF2357 (givinostat), a clinical-stage inhibitor of histone deacetylase (HDAC) activity, was effective in murine models of HFpEF. What do you think?
While February is American Heart Month, or Heart Health Month, the nursing profession is turning its attention towards leadership in cardiovascular disease prevention and awareness 12 months a year. Read 'Heart Health: Positive Impacts on Cardiovascular Health with new Blood Pressure Guidelines'
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? The answer is here
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. Read the full article
The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. View the statement
Rapid pollution increases may be as harmful to the heart as absolute levels. Link to press release plus reaction from the press
Maybe we were underestimating the burden of cardiovascular disease: nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months. Read the article in Cardiovascular News
The article was written following publication of The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up in the European Journal of Preventive Cardiology. 2018. Komajda M, et al.
Call to action: we need a flu shot study! Canadian research shows (Kwong JC, et al, New England Journal of Medicine, 2018) that the chances of a heart attack are increased six-fold during the first seven days after detection of laboratory-confirmed influenza infection, but if a flu shot can prevent this remains unclear. Read the review in Science Daily.
Heart failure with improved ejection fraction: is a newcomer in the family important? Prof. Petar Seferovic, President-Elect, published in the European Journal of Preventive Cardiology. Read the article
Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Find out more
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Read the paper
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. View the results
Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. Have a look at the analysis
Patients with heart failure who have anorexia are also more affected in their physical functional capacity and have worse prognosis. Researchers from Gottingen have described the impact of the serious condition anorexia in this article
It is never too late to pick up exercise! Researchers found that in previously sedentary healthy middle-aged adults, 2 years of exercise training improved maximal oxygen uptake and decreased cardiac stiffness and reduced the chance of developing heart failure.
Read the paper in Circulation
The heart is smart! It sees the difference between adverse stress (e.g. hypertension) and good stress (e.g. exercise). This elegant study was published in Nature Medicine
Sacubitril/valsartan may be beneficial in post MI heart failure, was suggested from an experimental study published last year
The HFA Winter Meeting on Translational Heart Failure Research takes place this week.
Discover the list of abstracts and presenting faculty. Abstracts will be published in the European Journal of Heart Failure in May
The journal has already started adding articles from 2018 to its list of Reviews. Bookmark the page for future reference
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. In European Journal of Heart Failure
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Read the article
What have we learned about heart failure with mid-range ejection fraction one year after its introduction? Read the article
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study Read the article
Evolving concepts in dilated cardiomyopathy. Read the article
Exercise and heart failure: an update. Read the article
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial. Read the article
Novel anti-fibrotic treatment may be of help in Heart Failure. By inhibiting interleukin-11 the authors of this study show that organ fibrosis can be attenuated. Read the article
Interesting study describing the cardiac proteome of 16 anatomical regions and three cardiac cell types by high-resolution mass spectrometry-based proteomics. Study text
The potential role and rationale for treatment of heart failure with sodium–glucose co-transporter 2 inhibitors. Read the article
The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets. Read the article
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Read the article
The Austrian, German and Swiss Working groups for heart failure are promoting the Award which is endowed with 5000€ and will be awarded for the second time in 2018.
Original scientific work accepted for publication between 2016 and 2018 can be submitted by anyone, including people not involved in the publication submitted. The work has to be predominately done in Europe, i.e. more than 50% of authors must be employed at a European facility.
The aim of this award is to commemorate Richard Pacher by supporting exceptional or unconventional approaches to heart failure research. We are aware that this research will often not be immediately recognized by high-ranking journals. Therefore, the judges will not evaluate journal quality. This award aims to create incentive and reward research that focuses on quality rather than on impact factor.
It will be awarded during the Heart Failure congress 2018 held in Vienna, Austria.
Submission deadline: 15th February 2018
Submit to Martin Hülsmann
Did you also read about the HFA Summit which took place on 4 November in Poland? The Polish Cardiac Society and other mediacal bodies signed a declaration on the management of patients with heart failure.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved